{"lastClose": 6.559999942779541, "len": 1172, "date": "2023-02-15", "alpha_1": -0.49025992137198704, "beta_1": 0.9279465983521125, "drawup_1": 1.3471616111515763, "natr_1": 10.60845739603118, "sup_1": -0.19207318306808427, "res_1": 0.2073170711023571, "bullPattern_1": ["SHORTLINE"], "bearPattern_1": [], "rsi_1": 46.25000102445451, "adx_1": 8.341271990615446, "drawdown_1": -0.750136391556512, "stratHoldSharpe_1": -0.5846629349987889, "stratHoldAlpha_1": 250.5676921922651, "stratHoldDrawdown_1": -0.6867369632958273, "alpha_3mo": -0.41508600953758845, "beta_3mo": 1.2442403177159067, "drawup_3mo": 0.2142857086279406, "natr_3mo": 10.60845739603118, "sup_3mo": -0.047256089250542095, "res_3mo": 0.03810975642997832, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 46.288209425130354, "adx_3mo": 23.12764271017016, "drawdown_3mo": -0.2291933386642222, "stratHoldSharpe_3mo": -0.7421384540628355, "stratHoldAlpha_3mo": 250.61812173217797, "stratHoldDrawdown_3mo": -0.20709602472462285, "Sector": "Health Care", "IPO Year": 2018.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 447305000, "Name": "Kezar Life Sciences Inc.", "Country": "United States", "alpha%_1": 0.09676751100388226, "beta%_1": 0.45365975967428274, "drawup%_1": 0.9863816051239553, "natr%_1": 0.9986048969575094, "drawdown%_1": 0.03317535499084696, "stratHoldSharpe%_1": 0.1544824453200233, "stratHoldAlpha%_1": 0.030620597693384728, "stratHoldDrawdown%_1": 0.03207364823311696, "alpha%_3mo": 0.14067373969262503, "beta%_3mo": 0.6948808772442758, "drawup%_3mo": 0.4079976852655757, "natr%_3mo": 0.9982979710183877, "drawdown%_3mo": 0.1459569567868339, "stratHoldSharpe%_3mo": 0.11801986381440455, "stratHoldAlpha%_3mo": 0.09323962277124503, "stratHoldDrawdown%_3mo": 0.14658975542759872}